| |
 |
Scientific Contribution |
|
|
 |
|
|
CCBR-SYNARC scientists developed many of the imaging and biochemical-marker applications used in clinical trials today.
CCBR-SYNARC's experts are leading authorities in the medical image analysis, subject recruitment and biochemical markers in drug development, and have helped develop many of the methods currently used in clinical trials. They have specialized training and experience
Claus Christiansen, M.D., Ph.D.
Harry K. Genant, M.D.
Nadia Bouzegaou, M.D.
Nadine Charni-ben Tabassi, Ph.D.
Pierre Colombel, MD
Klaus Engelke, Ph.D.
Dieter Felsenberg, M.D.
Daniel Fertek, MD
Anke Fierlinger, M.D.
Thomas Fuerst, Ph.D.
Claus Glüer, Ph.D.
Tomas Hala, M.D.
Didier Hans, Ph.D., P.A.
Hans Christian Hoeck, M.D., Ph.D.
Karina Hufert, MD,
Gabriele von Ingersleben, M.D., Ph.D.
Stepan Kutilek, MD, Ph.D.
Edith Lau, MD.
|
|
Michael McClung, M.D.
Souhila Ounadjela, M.D.
Paola Pettersen, M.D.
Caroline Reinhold, M.D., M.Sc.
Luis Russo, M.D.
Phil S. Schein, M.D., F.R.C.P.
Vahan Sharoyan, Ph.D.
Howard Simon, Ph.D.
Joyce Suhy, Ph.D.
Jan Szechinski, M.D.
Jörg Toschke, M.D.
Ivo Valter, MD
Michael W. Weiner, M.D.
David White, Ph.D.
Chunying Wu, M.D., Ph.D.
Souhil Zaim, M.D. |
|
|
|
|
